Literature DB >> 29113191

How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review.

Lin-Hui Hu1, Lian-Fang Pu1, Dong-Dong Yang1, Cui Zhang1, Hui-Ping Wang1, Yang-Yang Ding1, Man-Man Li1, Zhi-Min Zhai1, Shudao Xiong1.   

Abstract

The Philadelphia (Ph; BCR-ABL) chromosome originates from a translocation event between chromosomes 9 and 22, and results in the BCR-ABL fusion gene. In chronic myelogenous leukemia (CML), the BCR-ABL gene is mainly coded for by a major breakpoint cluster region (M-bcr, e13a2 and e14a2). However, in some patients, BCR-ABL genes are encoded by a minor (m)-bcr, e1a2, and a micro (µ)-bcr region, e19a2. These transcripts revealed a different clinical course. The present study described a CML patient whose cytogenetics and FISH analyses of bone marrow revealed a karyotype of 46, XY t(9,22) (q34;q11), while the commercial kits of quantitative PCR (qPCR) failed to detect the BCR-ABL fusion gene. Further multiplex Reverse transcription-PCR (RT-PCR) and sequencing analyses identified a rare e14a3 (b3a3) fusion transcript.

Entities:  

Keywords:  BCR-ABL; chronic myelogenous leukemia; e14a3

Year:  2017        PMID: 29113191      PMCID: PMC5652226          DOI: 10.3892/ol.2017.6847

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  B3/A3 rearrangement in a patient with chronic myeloid leukemia.

Authors:  César Paz-Y-Miño; Melissa Arévalo; Paola E Leone
Journal:  Leuk Lymphoma       Date:  2003-02

2.  Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.

Authors:  Benjamin Hanfstein; Michael Lauseker; Rüdiger Hehlmann; Susanne Saussele; Philipp Erben; Christian Dietz; Alice Fabarius; Ulrike Proetel; Susanne Schnittger; Claudia Haferlach; Stefan W Krause; Jörg Schubert; Hermann Einsele; Mathias Hänel; Jolanta Dengler; Christiane Falge; Lothar Kanz; Andreas Neubauer; Michael Kneba; Frank Stegelmann; Michael Pfreundschuh; Cornelius F Waller; Karsten Spiekermann; Gabriela M Baerlocher; Markus Pfirrmann; Joerg Hasford; Wolf-Karsten Hofmann; Andreas Hochhaus; Martin C Müller
Journal:  Haematologica       Date:  2014-05-16       Impact factor: 9.941

3.  LightCycler technology for the quantitation of bcr/abl fusion transcripts.

Authors:  K A Kreuzer; U Lass; A Bohn; O Landt; C A Schmidt
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

4.  Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors.

Authors:  Preetesh Jain; Hagop Kantarjian; Keyur P Patel; Graciela Nogueras Gonzalez; Rajyalakshmi Luthra; Rashmi Kanagal Shamanna; Koji Sasaki; Elias Jabbour; Carlos Guillermo Romo; Tapan M Kadia; Naveen Pemmaraju; Naval Daver; Gautam Borthakur; Zeev Estrov; Farhad Ravandi; Susan O'Brien; Jorge Cortes
Journal:  Blood       Date:  2016-01-04       Impact factor: 22.113

5.  Chronic myeloid leukemia with e14a3 BCR-ABL transcript: analysis of characteristics and prognostic significance.

Authors:  Xiaomin Gui; Yong Zhang; Jinlan Pan; Huiying Qiu; Jiannong Cen; Yongquan Xue; Suning Chen; Hongjie Shen; Li Yao; Jun Zhang; Yafang Wu; Yan Chen
Journal:  Leuk Lymphoma       Date:  2015-06-19

6.  A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: diagnostic challenges in clinical laboratory practice.

Authors:  Natini Jinawath; Alexis Norris-Kirby; B Douglas Smith; Christopher D Gocke; Denise A Batista; Constance A Griffin; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2009-06-04       Impact factor: 5.568

Review 7.  Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2.

Authors:  S Iwata; S Mizutani; S Nakazawa; J Yata
Journal:  Leukemia       Date:  1994-10       Impact factor: 11.528

8.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.

Authors:  A de Klein; A G van Kessel; G Grosveld; C R Bartram; A Hagemeijer; D Bootsma; N K Spurr; N Heisterkamp; J Groffen; J R Stephenson
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

9.  Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia.

Authors:  N Pallisgaard; P Hokland; D C Riishøj; B Pedersen; P Jørgensen
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

10.  Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.

Authors:  M Nieborowska-Skorska; M A Wasik; A Slupianek; P Salomoni; T Kitamura; B Calabretta; T Skorski
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

View more
  3 in total

1.  Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.

Authors:  Michele Massimino; Stefania Stella; Elena Tirrò; Maria Letizia Consoli; Maria Stella Pennisi; Adriana Puma; Silvia Rita Vitale; Chiara Romano; Valentina Zammit; Fabio Stagno; Francesco Di Raimondo; Livia Manzella
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

2.  Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript.

Authors:  Naoki Miyashita; Masahiro Onozawa; Keito Suto; Shinichi Fujisawa; Nanase Okazaki; Daisuke Hidaka; Hiroyuki Ohigashi; Atsushi Yasumoto; Junichi Sugita; Daigo Hashimoto; Yoshihiro Matsuno; Takanori Teshima
Journal:  Intern Med       Date:  2021-09-11       Impact factor: 1.282

3.  Chronic Myeloid Leukemia with b3a3 (e14a3) Fusion: A Rare BCR/ABL Rearrangement Presenting with Thrombocytosis - Does MTHFR Polymorphism Matter.

Authors:  Mohammad Muhsin Chisti; Daniel Steven Sanders
Journal:  Case Rep Oncol       Date:  2018-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.